Effect of adjuvant radioactive iodine therapy on survival in rare oxyphilic subtype of thyroid cancer (Hürthle cell carcinoma)

PURPOSE: Radioactive iodine (RAI) is widely used for adjuvant therapy after thyroidectomy, while its value for thyroid cancer has been controversial recently. The primary objectives of this study were to clarify the influence of Radioactive iodine (RAI) on the survival in rare oxyphilic subtype of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qiong, Zhao, Zhongsheng, Zhong, Guansheng, Jin, Aixiang, Yu, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716497/
https://www.ncbi.nlm.nih.gov/pubmed/31523497
http://dx.doi.org/10.7717/peerj.7458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716497/
https://www.ncbi.nlm.nih.gov/pubmed/31523497
http://dx.doi.org/10.7717/peerj.7458

Ejemplares similares